Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma

Antonio Grieco, Alessandro Cucchetti, Franco Trevisani, Anna Pecorelli, Virginia Erroi, Fabio Farinati, Francesca Ciccarese, Mariella Di Marco, Eugenio Caturelli, Edoardo G. Giannini, Marco Zoli, Franco Borzio, Giuseppe Cabibbo, Martina Felder, Rodolfo Sacco, Francesco Giuseppe Foschi, Gabriele Missale, Filomena Morisco, Gianluca Svegliati Baroni, Roberto VirdoneMauro Bernardi, Antonio D. Pinna

Risultato della ricerca: Contributo in rivistaArticolo in rivista

62 Citazioni (Scopus)

Abstract

Lead-time is the time by which diagnosis is anticipated by screening/surveillance with respect to the symptomatic detection of a disease. Any screening program, including surveillance for hepatocellular carcinoma (HCC), is subject to lead-time bias. Data regarding lead-time for HCC are lacking. Aims of the present study were to calculate lead-time and to assess its impact on the benefit obtainable from the surveillance of cirrhotic patients.
Lingua originaleEnglish
pagine (da-a)333-341
Numero di pagine9
RivistaJournal of Hepatology
Volume61
DOI
Stato di pubblicazionePubblicato - 2014

Keywords

  • Cirrhosis
  • Hepatocellular carcinoma
  • Lead-time bias
  • Surveillance

Fingerprint Entra nei temi di ricerca di 'Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma'. Insieme formano una fingerprint unica.

Cita questo